Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Rifamycin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 119Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Aemcolo

    02 2Aemcolo/Relafalk

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Aemcolo

    Rifamycin

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Aemcolo

    Ireland
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Cosmo Pharmaceuticals

    Rifamycin

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2020 Revenue in Millions : 0

    2019 Revenue in Millions : 1

    Growth (%) : -100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Aemcolo/Relafalk

    Rifamycin

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Aemcolo/Relafalk

    Ireland
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Cosmo Pharmaceuticals

    Rifamycin

    Main Therapeutic Indication : Gastrointestinal Diseases

    Currency : USD

    2022 Revenue in Millions : 0

    2021 Revenue in Millions : 2

    Growth (%) : -93

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Aemcolo/Relafalk

    Rifamycin

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Aemcolo/Relafalk

    Ireland
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Cosmo Pharmaceuticals

    Rifamycin

    Main Therapeutic Indication : Gastrointestinal Diseases

    Currency : USD

    2023 Revenue in Millions : 1

    2022 Revenue in Millions : 0

    Growth (%) : 435

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF